[미국특허]
Compositions and methods for generating chimeric heteromultimers
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
C07H-021/04
C07H-021/00
C12Q-001/70
C12P-021/04
C12N-007/00
C12N-015/00
C12N-005/06
A61K-039/395
C12P-021/08
출원번호
US-0911127
(2004-08-03)
등록번호
US-7429652
(2008-09-30)
발명자
/ 주소
Wang,Caili
Zhong,Pingyu
Liu,Shengjiang
Luo,Peizhi
Li,Shengfeng
Wang,Xinwei
출원인 / 주소
Abmaxis, Inc.
대리인 / 주소
Chisholm,Patricia L.
인용정보
피인용 횟수 :
34인용 특허 :
47
초록▼
The present invention provides a technique for specific assembly of monomeric polypeptides to form a heteromultimer. This technique is particularly useful for generating a genetically diverse repertoire of heteromultimers such as antigen-binding units. The invention also provides both non-single-cha
The present invention provides a technique for specific assembly of monomeric polypeptides to form a heteromultimer. This technique is particularly useful for generating a genetically diverse repertoire of heteromultimers such as antigen-binding units. The invention also provides both non-single-chain and single-chain antigen-binding units that are assembled by the technique described herein. The present invention also provides recombinant polynucleotides, vectors, host cells, and kits for producing the subject antigen-binding units. Further provided by the invention are methods of using the subject antigen-binding units.
대표청구항▼
What is claimed is: 1. A recombinant polynucleotide comprising a coding sequence that encodes a light (L) chain polypeptide of a non-single-chain antigen-binding unit, wherein the non-single-chain antigen-binding unit comprises: (a) the encoded light (L) chain polypeptide having a light (L) chain v
What is claimed is: 1. A recombinant polynucleotide comprising a coding sequence that encodes a light (L) chain polypeptide of a non-single-chain antigen-binding unit, wherein the non-single-chain antigen-binding unit comprises: (a) the encoded light (L) chain polypeptide having a light (L) chain variable region fused in-frame to a first heterodimerization polypeptide and (b) a heavy (H) chain polypeptide having a heavy (H) chain variable region fused in-frame to a second heterodimerization polypeptide wherein the L chain and the H chain polypeptides dimerize via pairwise affinity of the first and second heterodimerization polypeptides, said first and second heterodimerization polypeptides comprising heterodimeric receptor polypeptides that mediate heterodimerization. 2. A recombinant polynucleotide comprising a coding sequence that encodes a heavy (H) chain polypeptide of a non-single-chain antigen-binding unit, wherein the non-single-chain antigen-binding unit comprises: (a) a light (L) chain polypeptide comprising a light (L) chain variable region fused in-frame to a first heterodimerization polypeptide and (b) the encoded heavy (H) chain polypeptide comprising a heavy (H) chain variable region fused in-frame to a second heterodimerization polypeptide wherein the L chain and the H chain polypeptides dimerize via pairwise affinity of the first and second heterodimerization polypeptides, said first and second heterodimerization polypeptides comprising heterodimeric receptor sequences that mediate heterodimerization. 3. A recombinant polynucleotide comprising a first coding sequence that encodes the L chain polypeptide of claim 1, and a second coding sequence that encodes the H chain polypeptide of claim 2, wherein the L chain and the H chain polypeptides dimerize via pairwise affinity of the first and second heterodimerization polypeptides; and further wherein at least one of the heterodimerization polypeptides is essentially incapable of forming a homodimer under physiological buffer conditions and/or at physiological body temperatures. 4. A vector comprising the recombinant polynucleotide of claim 1, or 2. 5. The vector of claim 4, wherein the vector is an expression vector. 6. The vector of claim 4, wherein the vector is a phage display vector. 7. A selectable library of expression vectors encoding a repertoire of antigen binding units, comprising more than one vector of claim 4. 8. The selectable library of claim 7, wherein the vector is a phage display vector. 9. An isolated host cell comprising the vector of claim 4. 10. The isolated host cell of claim 9, wherein the recombinant polynucleotide encoding the L chain polypeptide and the polynucleotide encoding the H chain polypeptide, are present in a single vector. 11. The isolated host cell of claim 9, wherein the recombinant polynucleotide encoding the L chain polypeptide and the polynucleotide encoding the H chain polypeptide, are present in separate vectors. 12. The isolated host cell of claim 9, wherein the host cell is a eukaryotic cell. 13. The isolated host cell of claim 9, wherein the host cell is a prokaryotic cell. 14. A method of producing a non-single-chain antigen-binding unit, comprising: (a) expressing in a host cell a first recombinant polynucleotide encoding a light (L) chain polypeptide comprising a light (L) chain variable region fused in-frame to a first heterodimerization polypeptide, and a second recombinant polynucleotide encoding a heavy (H) chain polypeptide comprising a heavy (H) chain variable region fused in-frame to a second heterodimerization polypeptide; wherein the L chain and the H chain polypeptides dimerize via pairwise affinity of the first and second heterodimerization polypeptides and optionally (b) isolating the antigen-binding unit expressed in the host cell. 15. The method of claim 14, wherein the non-single-chain antigen-binding expressed in step (a) is displayed on surface of the host cell. 16. The method of claim 14, wherein the non-single-chain antigen-binding expressed in step (a) is displayed on a phage particle. 17. The method of claim 14, wherein the host cell is a eukaryotic cell. 18. The method of claim 14, wherein the host cell is a prokaryotic cell. 19. The method of 14, wherein the first and second heterodimerization polypeptides form a coiled-coil dimer. 20. The method of claim 14, wherein the L chain and the H chain polypeptides dimerize via non-covalent pairwise affinity. 21. The method of claim 19, wherein the L chain polypeptide further comprises a flexon that is flanked by the L chain variable region and the first heterodimerization polypeptide. 22. The method of claim 19, wherein the H chain polypeptide further comprises a flexon that is flanked by the H chain variable region and the second heterodimerization polypeptide. 23. The method of claim 19, wherein both the first and the second heterodimerization polypeptides are linked to at least one cysteine residue. 24. The method of claim 19, wherein the non-single-chain antigen-binding unit is multivalent. 25. The method of claim 19, wherein the non-single-chain antigen-binding unit is multispecific. 26. The method of claim 25, wherein the non-single-chain antigen-binding unit is bispecific. 27. The method of claim 25, wherein the non-single-chain antigen-binding unit is trispecific. 28. The method of claim 14, wherein the light (L) chain variable region is human. 29. The method of claim 14, wherein the heavy (H) chain variable region is human. 30. The method of claim 14, wherein the non-single-chain antigen-binding unit exhibits an apparent binding affinity at least one order of magnitude higher than that of a single-chain antigen-binding unit (scFv) that is stabilized by a peptide linker. 31. A kit comprising a vector of claim 4 in suitable packaging.
Fodor Stephen P. A. (Palo Alto CA) Pirrung Michael C. (Durham NC) Read J. Leighton (Palo Alto CA) Stryer Lubert (Stanford CA), Array of oligonucleotides on a solid substrate.
Brent Roger ; Xu C. Wilson ; Mendelsohn Andrew R. ; Lok Walter L., Detection systems for registering protein interactions and functional relationships.
Ladner Robert C. (Ijamsville MD) Guterman Sonia K. (Belmont MA) Roberts Bruce L. (Milford MA) Markland William (Milford MA) Ley Arthur C. (Newton MA) Kent Rachel B. (Boxborough MA), Directed evolution of novel binding proteins.
Ladner Robert Charles ; Gutterman Sonia Kosow ; Roberts Bruce Lindsay ; Markland William ; Ley Arthur Charles ; Kent Rachel Baribault, Directed evolution of novel binding proteins.
Georgiou George (11501 Juniper Ridge Dr. Austin TX 78759) Francisco Joseph A. (Austin TX) Earhart Charles F. (Austin TX), Expression of proteins on bacterial surface.
Queen Cary L. (Los Altos CA) Co Man Sung (Cupertino CA) Schneider William P. (Mountain View CA) Landolfi Nicholas F. (Milpitas CA) Coelingh Kathleen L. (San Francisco CA) Selick Harold E. (Belmont CA, Humanized immunoglobulins.
Pirrung Michael C. (Durham NC) Read J. Leighton (Palo Alto CA) Fodor Stephen P. A. (Palo Alto CA) Stryer Lubert (Stanford CA), Large scale photolithographic solid phase synthesis of an array of polymers.
Krebber Klaus (Zurich CHX) Moroney Simon (Munich DEX) Plckthun Andreas (Zurich CHX) Schneider Christian (Bergisch-Gladbach DEX), Method for in vivo selection of ligand-binding proteins.
Kinzler Kenneth W. (Bel Air MD) Vogelstein Bert (Baltimore MD) Velculescu Victor E. (Baltimore MD) Zhang Lin (Baltimore MD), Method for serial analysis of gene expression.
Johnson Kevin Stuart,GBX ; Winter Gregory Paul,GBX ; Griffiths Andrew David,GBX ; Smith Andrew John Hammond,GBX ; Waterhouse Peter Michael,AUX, Methods for producing members of specific binding pairs.
McCafferty John,GBX ; Pope Anthony Richard,GBX ; Johnson Kevin Stuart,GBX ; Hoogenboom Henricus Renerus Jacobus Mattheus,GBX ; Griffiths Andrew David,GBX ; Jackson Ronald Henry,GBX ; Holliger Kaspar , Methods for producing members of specific binding pairs.
Winter Gregory Paul,GBX ; Johnson Kevin Stuart,GBX ; Griffiths Andrew David,GBX ; Smith Andrew John Hammond,GBX, Methods for producing members of specific binding pairs.
Griffiths Andrew David,GBX ; Hoogenboom Hendricus Renerus Jacobus Mattheus,GBX ; Marks James David ; McCafferty John,GBX ; Winter Gregory Paul,GBX ; Grigg Geoffrey Walter,AUX, Production of anti-self antibodies from antibody segment repertoires and displayed on phage.
Crabtree Gerald R. ; Schreiber Stuart L. ; Spencer David M. ; Wandless Thomas J. ; Belshaw Peter, Regulated transcription of targeted genes and other biological events.
Winter Gregory Paul,GBX ; Ward Elizabeth Sally,GBX ; Gussow Detlef,GBX, Single domain ligands, receptors comprising said ligands methods for their production, and use of said ligands and receptors.
McGall Glenn H. (Mountain View CA) Fodor Stephen P. A. (Palo Alto CA) Sheldon Edward L. (Menlo Park CA), Spatially-addressable immobilization of oligonucleotides and other biological polymers on surfaces.
Koenig, Scott, Bispecific molecules that are immunoreactive with immune effector cells of a companion animal that express an activating receptor and cells that express B7-H3 and uses thereof.
Koenig, Scott; Johnson, Leslie S.; Lam, Chia-Ying Kao; Liu, Liqin; Nordstrom, Jeffrey Lee; Haynes, Barton F.; Ferrari, Guido, Bispecific molecules that are immunoreactive with immune effector cells that express an activating receptor and an antigen expressed by a cell infected by a virus and uses thereof.
Wasson, James; Frankovich, John Kent; Holmes, Elizabeth A.; Smith, Timothy; Chen, Michael; Young, Daniel, Systems and methods for fluid and component handling.
Holmes, Elizabeth A.; Pangarkar, Chinmay; Anekal, Samartha; Frankovich, John K.; Chen, Michael; Smith, Timothy, Systems and methods for multi-analysis.
Gibbons, Ian; Nugent, Anthony J.; Delacruz, Anthony; Young, Daniel L.; Holmes, Elizabeth A.; Drake, Andrew; Kemp, Timothy Michael; Balwani, Sunny; Pangarkar, Chinmay, Systems and methods for sample use maximization.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.